Patents matching “The United States of America, As Represented By”

US 6838090

Water-insoluble drug delivery system

The United States of America, as represented by the Department of Health and Human Services · Granted Jan 4, 2005 · Expires Dec 30, 2024

US 6833128

Method for monitoring local reaction associated with injections

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 21, 2004 · Expires Dec 16, 2024

US 6830893

T20/DP178 is an activator of human phagocyte formyl peptide receptors

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 14, 2004 · Expires Dec 9, 2024

US 6828416

Recombinant multivalent malarial vaccine against Plasmodium falciparum

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 7, 2004 · Expires Dec 2, 2024

US 6821511

Methods of using adeno-associated virus rep protein

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2004 · Expires Nov 18, 2024

US 6818749

Variants of humanized anti carcinoma monoclonal antibody cc49

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 16, 2004 · Expires Nov 11, 2024

US 6815173

Method for detecting syphilis using synthetic antigents

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 9, 2004 · Expires Nov 4, 2024

US 6812246

Aminoflavone compounds, compositions, and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2004 · Expires Oct 28, 2024

US 6808877

Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2004 · Expires Oct 21, 2024

US 6800475

Isolation of a human retrovirus

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 5, 2004 · Expires Sep 30, 2024

US 6797275

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2004 · Expires Sep 23, 2024

US 6794174

Full-length infectious cDNA clones of tick borne flavivirus

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6794188

Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6794498

Method of eliminating inhibitory/instability regions of mRNA

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 21, 2004 · Expires Sep 16, 2024

US 6790449

Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2004 · Expires Sep 9, 2024

US 6790936

CAI resistance proteins and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2004 · Expires Sep 9, 2024

US 6787333

Retrovirus isolated from humans

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 7, 2004 · Expires Sep 2, 2024

US 6780417

Transmission blocking immunogen from malaria

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6780847

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6780413

Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2004 · Expires Aug 19, 2024

US 6773880

Streptococcus pneumoniale 37-kDa surface adhesion A protein

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2004 · Expires Aug 5, 2024

US 6770291

Liposome complexes for increased systemic delivery

The United States of America, as represented by the Department of Health and Human Services · Granted Aug 3, 2004 · Expires Jul 29, 2024

US 6767546

Use of echinacea as a feed additive to enhance protection against coccidiosis

The United States of America, as represented by the Secretary of Agriculture · Granted Jul 27, 2004 · Expires Jul 22, 2024

US 6765104

Transition metal complexes of n, n',n″trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use

The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2004 · Expires Jul 15, 2024